BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38517798)

  • 1. Assessment of Perivascular Space Morphometry Across the White Matter in Huntington's Disease Using MRI.
    Coleman A; Langan MT; Verma G; Knights H; Sturrock A; Leavitt BR; Tabrizi SJ; Scahill RI; Hobbs NZ
    J Huntingtons Dis; 2024; 13(1):91-101. PubMed ID: 38517798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Dilated Perivascular Spaces and Disease Severity in Patients With Huntington Disease.
    Chan ST; Mercaldo ND; Ravina B; Hersch SM; Rosas HD
    Neurology; 2021 Feb; 96(6):e890-e894. PubMed ID: 33106388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early grey matter changes in structural covariance networks in Huntington's disease.
    Coppen EM; van der Grond J; Hafkemeijer A; Rombouts SA; Roos RA
    Neuroimage Clin; 2016; 12():806-814. PubMed ID: 27830113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis.
    Tabrizi SJ; Scahill RI; Durr A; Roos RA; Leavitt BR; Jones R; Landwehrmeyer GB; Fox NC; Johnson H; Hicks SL; Kennard C; Craufurd D; Frost C; Langbehn DR; Reilmann R; Stout JC;
    Lancet Neurol; 2011 Jan; 10(1):31-42. PubMed ID: 21130037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White and Gray Matter Abnormalities in Manifest Huntington's Disease: Cross-Sectional and Longitudinal Analysis.
    Sweidan W; Bao F; Bozorgzad NS; George E
    J Neuroimaging; 2020 May; 30(3):351-358. PubMed ID: 32128927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linking white matter and deep gray matter alterations in premanifest Huntington disease.
    Faria AV; Ratnanather JT; Tward DJ; Lee DS; van den Noort F; Wu D; Brown T; Johnson H; Paulsen JS; Ross CA; Younes L; Miller MI;
    Neuroimage Clin; 2016; 11():450-460. PubMed ID: 27104139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered iron and myelin in premanifest Huntington's Disease more than 20 years before clinical onset: Evidence from the cross-sectional HD Young Adult Study.
    Johnson EB; Parker CS; Scahill RI; Gregory S; Papoutsi M; Zeun P; Osborne-Crowley K; Lowe J; Nair A; Estevez-Fraga C; Fayer K; Rees G; Zhang H; Tabrizi SJ;
    EBioMedicine; 2021 Mar; 65():103266. PubMed ID: 33706250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo characterization of white matter pathology in premanifest huntington's disease.
    Zhang J; Gregory S; Scahill RI; Durr A; Thomas DL; Lehericy S; Rees G; Tabrizi SJ; Zhang H;
    Ann Neurol; 2018 Oct; 84(4):497-504. PubMed ID: 30063250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term hemodialysis may affect enlarged perivascular spaces in maintenance hemodialysis patients: evidence from a pilot MRI study.
    Wang H; Han X; Li M; Yang ZH; Liu WH; Wang ZC
    Quant Imaging Med Surg; 2022 Jan; 12(1):341-353. PubMed ID: 34993083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural variation in sensory-motor white matter organization influences manifestations of Huntington's disease.
    Orth M; Gregory S; Scahill RI; Mayer IS; Minkova L; Klöppel S; Seunarine KK; Boyd L; Borowsky B; Reilmann R; Bernhard Landwehrmeyer G; Leavitt BR; Roos RA; Durr A; Rees G; Rothwell JC; Langbehn D; Tabrizi SJ;
    Hum Brain Mapp; 2016 Dec; 37(12):4615-4628. PubMed ID: 27477323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal change in white matter microstructure in Huntington's disease: The IMAGE-HD study.
    Poudel GR; Stout JC; Domínguez D JF; Churchyard A; Chua P; Egan GF; Georgiou-Karistianis N
    Neurobiol Dis; 2015 Feb; 74():406-12. PubMed ID: 25497085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational quantification of brain perivascular space morphologies: Associations with vascular risk factors and white matter hyperintensities. A study in the Lothian Birth Cohort 1936.
    Ballerini L; Booth T; Valdés Hernández MDC; Wiseman S; Lovreglio R; Muñoz Maniega S; Morris Z; Pattie A; Corley J; Gow A; Bastin ME; Deary IJ; Wardlaw J
    Neuroimage Clin; 2020; 25():102120. PubMed ID: 31887717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural neuroimaging differentiates vulnerability from disease manifestation in colombian families with Huntington's disease.
    Valdés Hernández MDC; Abu-Hussain J; Qiu X; Priller J; Parra Rodríguez M; Pino M; Báez S; Ibáñez A
    Brain Behav; 2019 Aug; 9(8):e01343. PubMed ID: 31276317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed longitudinal and cross-sectional analyses of deep gray matter and white matter using diffusion weighted images in premanifest and manifest Huntington's disease.
    Hu B; Younes L; Bu X; Liu CF; Ratnanather JT; Paulsen J; Georgiou-Karistianis N; Miller MI; Ross C; Faria AV
    Neuroimage Clin; 2023; 39():103493. PubMed ID: 37582307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.
    Novak MJ; Seunarine KK; Gibbard CR; Hobbs NZ; Scahill RI; Clark CA; Tabrizi SJ
    Cortex; 2014 Mar; 52():98-112. PubMed ID: 24405816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural brain correlates of dementia in Huntington's disease.
    Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
    Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.
    Minkova L; Gregory S; Scahill RI; Abdulkadir A; Kaller CP; Peter J; Long JD; Stout JC; Reilmann R; Roos RA; Durr A; Leavitt BR; Tabrizi SJ; Klöppel S;
    Neuroimage Clin; 2018; 17():312-324. PubMed ID: 29527479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain structure in juvenile-onset Huntington disease.
    Tereshchenko A; Magnotta V; Epping E; Mathews K; Espe-Pfeifer P; Martin E; Dawson J; Duan W; Nopoulos P
    Neurology; 2019 Apr; 92(17):e1939-e1947. PubMed ID: 30971481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microstructural brain abnormalities in Huntington's disease: A two-year follow-up.
    Odish OF; Leemans A; Reijntjes RH; van den Bogaard SJ; Dumas EM; Wolterbeek R; Tax CM; Kuijf HJ; Vincken KL; van der Grond J; Roos RA
    Hum Brain Mapp; 2015 Jun; 36(6):2061-74. PubMed ID: 25644819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.